Moderna Reports Promising Results in Phase Three Trial of Flu Vaccine, Progressing Towards Approval
In a recent late-stage trial, Moderna announced that its experimental mRNA-based flu vaccine demonstrated a stronger immune response against four strains of the virus compared to the currently available flu vaccine. This
